The Global Juvenile Macular Degeneration Market is expected to grow at a CAGR of ~7.2 % during the forecast period 2017-2023. Macular degeneration is a group of eye diseases commonly found among children and adults. There are various types of macular degeneration affecting the teens such as Cone-Rod Dystrophy, Best disease, Stargardt disease, Corneal Dystrophy, Fuch’s Dystrophy. Best disease, and Stargardtd disease are the most common types of macular degeneration, from which Stargardt Disease is an inherited juvenile degeneration characterized by the reduced central vision.
Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/4935 .
Rising prevalence of macular degeneration diseases among children, increasing demand for new treatment options, and extensive research and development activities drives the growth of the market. Furthermore, rising awareness about healthcare and growing emphasis on child health also fuel the growth of the market in developing regions late diagnosis of juvenile macular degeneration emphasis the need for early diagnosis and treatment further boosting the growth of the market. According to the World Health Organization (WHO), 285 million people are estimated to be visually impaired worldwide.
Juvenile Macular Degeneration Market Segmentation:
The Global Juvenile Macular Degeneration (Stargardt Disease) Market is segmented on the basis of diagnosis, and treatment.
On the basis of diagnosis, the market is segmented into visual field testing, color testing, Optical Coherence Tomography (OCT), and Electroretinography (ERG).
On the basis of treatment, the market is segmented into stem cell therapy, and gene therapy.
On the basis of devices, the market is segmented into magnifiers, reading glasses, absorptive filters, and others.
Juvenile Macular Degeneration Market Regional Analysis:
In America, the market for juvenile macular degeneration is driven by rising prevalence of macular degeneration among children, and availability of various treatment options for the treatment of the diseases. Furthermore, concentration of key market players also fuels the growth of the market. Furthermore, rapid developments in technology have fuelled the growth of the market. As per the World Health Organization (WHO), nearly 11 million people in the U.S. have some form of age-related macular degeneration and the number is expected to reach nearly 22 million by 2050.
Europe holds the second largest Juvenile Macular Degeneration (Stargardt Disease) market whose market is driven by the increasing number of clinical trials, and availability of funds for research. There is an increasing demand for new eye care device and supplements across European countries such Germany, France, and U.K.
Asia Pacific is expected to be the fastest growing market owing to the availability of skilled professional such as ophthalmologist, and eye surgeons. Additionally, improving healthcare infrastructure in the developing countries like India, further fuel the growth of juvenile macular degeneration market. China and India contribute to the growth of the market.
On the other hand, the Middle East & Africa hold the least share of the market due to low prevalence of macular degeneration in the region and limited availability of funds and availability of medical facilities. The Middle East dominates juvenile macular degeneration market due to the presence of well-developed countries like Kuwait, Qatar, Oman and Saudi Arabia. However, due to the presence of huge opportunities for the development of the market, Africa region is expecting a healthy growth.
Some of key the players in the market are Acucela Inc. (U.S.), Alkeus Pharmaceuticals Inc. (U.S.), Astellas Pharma Inc. (Japan), Allergan PLC (Ireland), Bausch + Lomb (U.S.), Pfizer (U.S.), Santen Pharmaceuticals (Japan), Gilead Sciences Inc. (U.S.), ProQR Therapeutics NV (The Netherland), Sanofi (France), Bayer HealthCare (Germany), F. Hoffmann-La Roche (Switzerland), Novartis AG (Switzerland), Regeneron Pharmaceuticals (U.S.), Copernicus Therapeutics Inc (U.S.), Grupo Ferrer Internacional SA (U.S.), Iris Pharma (U.S.), Nemus Bioscience Inc (U.S.), Ophthotech Corp (U.S.), Iconic Therapeutics (U.S.), Adverum Biotechnologies (U.S.), PanOptica (U.S.), RXi Pharmaceuticals (U.S.), Neurotech Pharmaceuticals (U.S.).
Order a 85 Premium Copy @ https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=4935 .
Table of Content for Juvenile Macular Degeneration Market:
- 1. Report Prologue
2. Market Introduction
2.2 Scope of the Study
2.2.1 Research Objective
3. Research Methodology
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
Ask to Expert @ https://www.marketresearchfuture.com/sample_request/4935 .
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Phone: +1 646 845 9312